Tarsus Pharmaceuticals Inc TARS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
36.35UNCH (UNCH)
Volume
145,844
Close
36.35UNCH (UNCH)
Volume
887,368
52 week range
11.33 - 40.40
Loading...
  • Open34.25
  • Day High37.16
  • Day Low34.24
  • Prev Close34.57
  • 52 Week High40.40
  • 52 Week High Date02/28/24
  • 52 Week Low11.33
  • 52 Week Low Date04/17/23

Key Stats

  • Market Cap1.363B
  • Shares Out37.49M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change79.51

KEY STATS

  • Open34.25
  • Day High37.16
  • Day Low34.24
  • Prev Close34.57
  • 52 Week High40.40
  • 52 Week High Date02/28/24
  • 52 Week Low11.33
  • 52 Week Low Date04/17/23
  • Market Cap1.363B
  • Shares Out37.49M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.05
  • YTD % Change79.51

RATIOS/PROFITABILITY

  • EPS (TTM)-4.58
  • P/E (TTM)-7.93
  • Fwd P/E (NTM)-7.61
  • EBITDA (TTM)-142.281M
  • ROE (TTM)-69.71%
  • Revenue (TTM)17.447M
  • Gross Margin (TTM)90.87%
  • Net Margin (TTM)-778.89%
  • Debt To Equity (MRQ)15.14%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tarsus Pharmaceuticals Inc

 

Profile

MORE
Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics, starting with eye care. The Company’s lead product candidate, XDEMVY is a lotilaner ophthalmic solution that targets and eradicates the root cause of Demodex blepharitis, Demodex mite infestation. The active pharmaceutical ingredient (API) of XDEMVY, lotilaner, paralyzes and eradicates mites and other parasites through...
Bobak Azamian M.D., Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Seshadri Neervannan Ph.D.
Chief Operating Officer
Jeffrey Farrow
Chief Financial Officer and Chief Strategy Officer
Bryan Wahl M.D., J.D.
General Counsel, Secretary
Address
15440 Laguna Canyon Road
Irvine, CA
92618
United States

Top Peers

SYMBOLLASTCHG%CHG
LQDA
Liquidia Corp
14.75UNCHUNCH
IMNM
Immunome Inc
24.68UNCHUNCH
PHVS
Pharvaris NV
23.11UNCHUNCH
SRRK
Scholar Rock Holding Corp
17.76UNCHUNCH
BLTE
Belite Bio Inc
38.37UNCHUNCH